Schedules of Controlled Substances: Temporary Placement of 7- Hydroxymitragynine and Mitragynine Pseudoindoxyl Above a Specified Threshold in Schedule I
2026-20943 | Drug Enforcement Administration | Proposed rule | Oct 14 |
Schedules of Controlled Substances: Temporary Placement of MGM-15 and MGM-16 in Schedule I
2026-20942 | Drug Enforcement Administration | Proposed rule | Oct 14 |
Schedules of Controlled Substances: Placement of O-Desmethyltramadol in Schedule I; Correction
2026-20748 | Drug Enforcement Administration | Final rule | Oct 9 |
Extension of Reexportation Period.
2026-20084 | Drug Enforcement Administration | Proposed rule | Oct 1 |
Schedules of Controlled Substances: Placement of 4-Hydroxy-N,N-Diisopropyltryptamine (4-OH-DiPT), 5-Methoxy-alpha-Methyltryptamine (5-MeO-AMT), 5-Methoxy-N-Methyl-N-Isopropyltryptamine (5-MeO-MiPT), 5-Methoxy-N,N-Diethyltryptamine (5-MeO-DET), and N,N-Diisopropyltryptamine (DiPT) Into Schedule I
2026-19400 | Drug Enforcement Administration | Proposed rule | Sep 23 |
Schedules of Controlled Substances: Placement of Diphenidine in Schedule I
2026-19231 | Drug Enforcement Administration | Final rule | Sep 21 |
Schedules of Controlled Substances: Placement of Cipepofol in Schedule IV
2026-17536 | Drug Enforcement Administration | Final rule | Aug 27 |
Schedules of Controlled Substances: Temporary Placement of 5,6-Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
2026-17531 | Drug Enforcement Administration | Final rule | Aug 27 |
Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
2026-17429 | Drug Enforcement Administration | Final rule | Aug 26 |
Withdrawal of International Airport Designation of Chalk Seaplane Base
2026-17108 | U.S. Customs and Border Protection | Proposed rule | Aug 21 |
Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I
2026-16413 | Drug Enforcement Administration | Final rule | Aug 12 |
Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant From Schedule IV Into Schedule V
2026-16375 | Drug Enforcement Administration | Proposed rule | Aug 11 |
Amendment to 3,4-MDP-2-P Methyl Glycidic Acid, a List I Chemical
2026-15624 | Drug Enforcement Administration | Proposed rule | Aug 3 |
Designation of Phenethyl Halides as List I Chemicals
2026-13825 | Drug Enforcement Administration | Proposed rule | Jul 9 |
Schedules of Controlled Substances: Placement of Tianeptine in Schedule I
2026-13821 | Drug Enforcement Administration | Proposed rule | Jul 8 |
Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
2026-13581 | Drug Enforcement Administration | Proposed rule | Jul 6 |
Schedules of Controlled Substance: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I
2026-13580 | Drug Enforcement Administration | Proposed rule | Jul 6 |
Enabling Supersonic Overland Flight
2026-13440 · significant | Federal Aviation Administration | Proposed rule | Jul 2 |
Schedules of Controlled Substances: Temporary Placement of 5,6- Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
2026-13364 | Drug Enforcement Administration | Proposed rule | Jul 1 |
Mechanic Certification: Inspection Rating and Recent Experience Requirements
2026-13282 | Federal Aviation Administration | Proposed rule | Jul 1 |
Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I
2026-12654 | Drug Enforcement Administration | Final rule | Jun 24 |
Schedules of Controlled Substances: Placement of Bromazolam in Schedule I; Correction
2026-12653 | Drug Enforcement Administration | Final rule | Jun 24 |
Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
2026-11526 · significant | Drug Enforcement Administration | Final rule | Jun 9 |
Schedules of Controlled Substances: Placement of Diphenidine in Schedule I
2026-10380 | Drug Enforcement Administration | Proposed rule | May 26 |
Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
2026-10253 | Drug Enforcement Administration | Final rule | May 22 |
Revision of Applications for Manufacturing and Procurement Quotas
2026-10128 · significant | Drug Enforcement Administration | Proposed rule | May 20 |
Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I
2026-09566 | Drug Enforcement Administration | Final rule | May 13 |
Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance
2026-08595 | Drug Enforcement Administration | Final rule | May 4 |
Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I
2026-08517 | Drug Enforcement Administration | Final rule | May 1 |
Schedules of Controlled Substances: Rescheduling of Food and Drug Administration Approved Products Containing Marijuana From Schedule I to Schedule III; Corresponding Change to Permit Requirements
2026-08176 | Drug Enforcement Administration | Final rule | Apr 28 |
Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I
2026-08104 | Drug Enforcement Administration | Final rule | Apr 24 |
Designation of P2P Methyl Glycidic Acid as a List I Chemical
2026-06523 | Drug Enforcement Administration | Final rule | Apr 3 |
Removal of Regulatory Overreach and Federal Crop Insurance Policy Provisions
2026-06277 | Federal Crop Insurance Corporation | Final rule | Apr 1 |
Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I
2026-05618 | Drug Enforcement Administration | Final rule | Mar 23 |
Ordering Schedule I and II Controlled Substances Using DEA Form 222; Technical Amendments
2026-05482 | Drug Enforcement Administration | Final rule | Mar 20 |
Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I
2026-05064 | Drug Enforcement Administration | Final rule | Mar 16 |
Designation of Propionyl Chloride as a List I Chemical
2026-04657 | Drug Enforcement Administration | Final rule | Mar 10 |
Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act
2026-04112 | Drug Enforcement Administration | Final rule | Mar 2 |
Electronic Bond Transmission
2026-02961 · significant | U.S. Customs and Border Protection | Proposed rule | Feb 13 |
Registering Emergency Medical Services Agencies Under the Protecting Patient Access to Emergency Medications Act of 2017
2026-02288 · significant | Drug Enforcement Administration | Final rule | Feb 5 |
Enhanced Air Cargo Advance Screening (ACAS); Corrections
2026-01167 · significant | U.S. Customs and Border Protection | Final rule | Jan 22 |
Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
2026-00954 | Drug Enforcement Administration | Proposed rule | Jan 20 |
Definition of “Cannabimimetic Agents” and Assignment of an Administration Controlled Substances Code Number for All “Cannabimimetic Agents”
2026-00907 | Drug Enforcement Administration | Final rule | Jan 20 |
Schedules of Controlled Substances: Placement of 4-Fluoroamphetamine in Schedule I
2026-00633 | Drug Enforcement Administration | Final rule | Jan 15 |
Schedules of Controlled Substances: Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I
2026-00362 | Drug Enforcement Administration | Final rule | Jan 12 |
Changes to Agriculture Risk Coverage, Price Loss Coverage, and Dairy Margin Coverage Programs
2026-00313 | Commodity Credit Corporation | Final rule | Jan 12 |
Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications
2025-24123 · significant | Health and Human Services Department | Final rule | Dec 31, 2025 |
Schedules of Controlled Substances: Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I
2025-23717 | Drug Enforcement Administration | Final rule | Dec 23, 2025 |
Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I
2025-22963 | Drug Enforcement Administration | Proposed rule | Dec 16, 2025 |
Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I
2025-22763 | Drug Enforcement Administration | Proposed rule | Dec 15, 2025 |
Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I
2025-22495 | Drug Enforcement Administration | Proposed rule | Dec 11, 2025 |
Expanding Access to Risk Protection (EARP)
2025-21482 | Federal Crop Insurance Corporation | Final rule | Nov 28, 2025 |
Enhanced Air Cargo Advance Screening (ACAS)
2025-20606 · significant | U.S. Customs and Border Protection | Final rule | Nov 21, 2025 |
Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I
2025-20004 | Drug Enforcement Administration | Final rule | Nov 17, 2025 |
Schedules of Controlled Substances: Temporary Placement of Ethyleneoxynitazene, Methylenedioxynitazene, 5-Methyl Etodesnitazene, N-Desethyl Etonitazene, N-Desethyl Protonitazene, N,N-Dimethylamino Etonitazene, and N-Pyrrolidino Isotonitazene in Schedule I
2025-19542 | Drug Enforcement Administration | Final rule | Oct 15, 2025 |
Designation of P2P Methyl Glycidic Acid as a List I Chemical
2025-19384 | Drug Enforcement Administration | Proposed rule | Oct 2, 2025 |
Specific Listing for 1-boc-4-piperidone, a Currently Controlled List I Chemical
2025-19349 | Drug Enforcement Administration | Final rule | Oct 2, 2025 |
Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I
2025-19348 | Drug Enforcement Administration | Proposed rule | Oct 2, 2025 |
Controlled Substances Ordering System (CSOS) Modernization
2025-19325 | Drug Enforcement Administration | Final rule | Oct 2, 2025 |
Requiring Online Submission of Applications for and Renewals of DEA Registration: Technical Correction
2025-19292 | Drug Enforcement Administration | Final rule | Oct 2, 2025 |
Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I
2025-18103 | Drug Enforcement Administration | Final rule | Sep 18, 2025 |
Schedules of Controlled Substances: Temporary Placement of N-pyrrolidino metonitazene and N-pyrrolidino protonitazene in Schedule I
2025-15566 | Drug Enforcement Administration | Final rule | Aug 15, 2025 |
Specific Listing for Dipentylone, a Currently Controlled Schedule I Substance
2025-15177 | Drug Enforcement Administration | Final rule | Aug 8, 2025 |
Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act
2025-14022 | Drug Enforcement Administration | Proposed rule | Jul 25, 2025 |
Schedules of Controlled Substances: Temporary Placement of Seven Benzimidazole-Opioids in Schedule I
2025-11462 | Drug Enforcement Administration | Proposed rule | Jun 26, 2025 |
Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-[1-(3-methoxyphenyl)cyclohexyl]piperidine) in Schedule I
2025-10503 | Drug Enforcement Administration | Proposed rule | Jun 10, 2025 |
Schedules of Controlled Substances: Placement of Three Specific Fentanyl-Related Substances in Schedule I
2025-10372 | Drug Enforcement Administration | Proposed rule | Jun 10, 2025 |
Schedules of Controlled Substances: Placement of 2-Methyl AP-237 in Schedule I; Correction
2025-09989 | Drug Enforcement Administration | Final rule | Jun 3, 2025 |
Schedules of Controlled Substances: Placement of 4-Fluoroamphetamine in Schedule I
2025-09988 | Drug Enforcement Administration | Proposed rule | Jun 3, 2025 |
Designation of Propionyl Chloride as a List I Chemical
2025-09983 | Drug Enforcement Administration | Proposed rule | Jun 3, 2025 |
Special Registrations for Telemedicine and Limited State Telemedicine Registrations
2025-01099 · significant | Drug Enforcement Administration | Proposed rule | Jan 17, 2025 |
Expansion of Buprenorphine Treatment via Telemedicine Encounter
2025-01049 · significant | Health and Human Services Department | Final rule | Jan 17, 2025 |
Continuity of Care via Telemedicine for Veterans Affairs Patients
2025-01044 · significant | Health and Human Services Department | Final rule | Jan 17, 2025 |
Multifamily Housing Program Update to the Credit Report Process
2024-31388 | Rural Housing Service | Final rule | Dec 31, 2024 |
Schedules of Controlled Substances: Extension of Temporary Placement of Seven Specific Fentanyl-Related Substances in Schedule I of the Controlled Substances Act
2024-31130 | Drug Enforcement Administration | Final rule | Dec 30, 2024 |
Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I
2024-30798 | Drug Enforcement Administration | Proposed rule | Dec 30, 2024 |
Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I
2024-30359 | Drug Enforcement Administration | Proposed rule | Dec 30, 2024 |
Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene Substances in Schedule I
2024-24635 | Drug Enforcement Administration | Final rule | Oct 25, 2024 |
Schedules of Controlled Substances: Placement of Ethylphenidate in Schedule I
2024-24083 | Drug Enforcement Administration | Final rule | Oct 22, 2024 |
Schedules of Controlled Substances: Temporary Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I
2024-21058 | Drug Enforcement Administration | Proposed rule | Sep 17, 2024 |
Schedules of Controlled Substances: Placement of Zuranolone in Schedule IV
2024-18087 | Drug Enforcement Administration | Final rule | Aug 14, 2024 |
Schedules of Controlled Substances: Temporary Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I
2024-16391 | Drug Enforcement Administration | Final rule | Jul 29, 2024 |
Expanding Options for Specialty and Organic Growers (EOSOG)
2024-13198 | Federal Crop Insurance Corporation | Final rule | Jun 27, 2024 |
Schedules of Controlled Substances: Rescheduling of Marijuana
2024-11137 | Drug Enforcement Administration | Proposed rule | May 21, 2024 |
Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene Substances in Schedule I
2024-07694 | Drug Enforcement Administration | Proposed rule | Apr 11, 2024 |
Schedules of Controlled Substances: Placement of Etodesnitazene, N-Pyrrolidino Etonitazene, and Protonitazene in Schedule I
2024-07684 | Drug Enforcement Administration | Final rule | Apr 11, 2024 |
Multifamily Housing Program Update to the Credit Report Process
2024-06596 | Rural Housing Service | Proposed rule | Mar 29, 2024 |
Schedules of Controlled Substances: Placement of 2-Methyl AP-237 in Schedule I
2024-05543 | Drug Enforcement Administration | Final rule | Mar 15, 2024 |
Conforming Amendment Regarding the Veterinary Medicine Mobility Act of 2014
2024-02322 · significant | Drug Enforcement Administration | Final rule | Feb 8, 2024 |
Falsification, Reproduction, Alteration, Omission, or Incorrect Statements
2024-00872 | Federal Aviation Administration | Proposed rule | Feb 8, 2024 |